ANI (ANIP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Whether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck. How do you find the right combination ...

Here are four drug and biotech stocks, ARQT, MESO, MNPR and KOD, which have more than doubled in 2024 with room for further growth in 2025.

Investors might want to bet on Tenet Healthcare (THC), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Caterpillar (CAT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

In the closing of the recent trading day, AppLovin (APP) stood at $344.82, denoting a +1.12% change from the preceding trading day.

ACM Research (ACMR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

IBM, GOOGL and NVDA are poised to capture the $45B agentic AI market in 2025 as enterprise adoption accelerates beyond ...

As consumer preferences continue to evolve toward health and value-driven purchases, TSN, STZ, FRPT, PG and CL are well-placed for growth in 2025.